Novartis Investigative Site

Foxborough, Massachusetts 02035

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies — Completed
• A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod — Completed